Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Proteinuria in IgA Nephropathy
NCT02942381Phase 2Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in IgA nephropathy (IgAN) comparing Hydroxychloroquine Sulfate with Placebo (2 arms). Primary endpoint: Proteinuria at 6 months. Started Sep 2016; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02942381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942381.